award

The Cure Sickle Cell Initiative Economic Analysis: An Evaluation of the Costs of Sickle Cell Disease and Potential Health Plan Budget Impacts of Gene Therapy as a New Treatment Option

  • Award Number: OT3HL151434

  • ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: OTHER

  • PERIOD OF PERFORMANCE START DATE: 07/01/2019

  • PERIOD OF PERFORMANCE END DATE: 06/30/2023